ERYTECH PHARMA is expected to look into its books on March 8th, 2021: At the quarterly financial conference, ERYTECH PHARMA will disclose the balance sheet for the quarter ended on December 31st, 2020.
On average, 2 analysts estimate that ERYTECH PHARMA posted a loss of EUR -0.900 per share in the last quarter of the year. In the same quarter of the previous year it was EUR -1.080 per share.
ERYTECH PHARMA is expected to have closed the last quarter with an average turnover of 1.9 million EUR – 2 analysts expect that on average. Accordingly, the company would have increased sales by 37.86 percent compared to the same quarter of the previous year, in which EUR 1.4 million had been earned.
3 analysts put out estimates of an average of EUR -3.677 per share for the past fiscal year, which would be a loss in view of the previous fiscal year. At that time, EUR -3.490 per share had been earned. In terms of sales, 4 analysts are assuming an average of EUR 4.8 million for the fiscal year just ended, compared to EUR 5.3 million in the corresponding period before.
[ source link ]
estimates ERYTECH PHARMA presents quarterly results quarter